ClinicalTrials.Veeva

Menu

Evaluation of Surfactant Protein B in the Differential Diagnostics of Dyspnea

U

Universitätsmedizin Mannheim

Status

Completed

Conditions

Dyspnea
Cardiac Disease
Pulmonary Disease

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT01197586
2010_spb_ma

Details and patient eligibility

About

Establishing new biochemical markers in the differential diagnostics and risk stratification in heterogeneous patient collectives is becoming more and more important. The markers should be objective, reliable, reproducible, quick and cost effective as well as specific and sensitive. Concerning the differential diagnostics of "dyspnea", NT-pro-BNP plays the most important role for the evaluation of a cardiac origin. However, a corresponding biochemical marker for pulmonary stress is lacking. The aim of the study at hand therefore was the evaluation of surfactant protein B in the differential diagnostics of pulmonary and cardiac diseases.

Enrollment

55 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients presenting with dyspnea and giving informed consent

Exclusion criteria

  • outpatients
  • lack or doubt of legal competence
  • indication for mechanical ventilation
  • pregnancy
  • palliative patients
  • CPAP/LTOT
  • BMI > 30 kg/m2
  • sepsis
  • anemia
  • dialysis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems